期刊文献+

重组腺病毒载体介导报告基因经多种途径转染至大鼠肾脏 被引量:2

Recombinant adenovirus vector-delivered report gene expression in rats kidney through different ways
下载PDF
导出
摘要 目的研究重组腺病毒(rAV)介导报告基因绿色荧光蛋白(GFP)能否转染到大鼠肾组织,以及多种途径转染的差异。方法30只大鼠随机分成5组,经5种途径注射rAV-GFP(1013个病毒颗粒·L-1)溶液,注射后2、7和14d,分别取各组大鼠的左肾、右肾、肝脏和肺,荧光显微镜观察,并通过计算机软件评价报告基因在肾组织中的表达情况。结果各种注射方式均可使绿色荧光蛋白在肾中表达,注射后7d时GFP表达达到高峰,并以腹腔和尾静脉注射方式表达最强;经肾动脉注射的靶向性较其他方式好。结论rAV载体能携带报告基因到肾组织,rAV可以用于肾疾病的基因治疗,且各种注射方式各有优缺点。 Objective To investigate expression of recombinant adenovirus (rAV) vector-mediated report gene in kidney, and to seek for the best passway of rAV vector-mediated gene transfer in vivo. Methods Thirty Sprague- Dawley(SD) rats were divided into 5 groups randomly, rAV-GFP( 1013viral particales · L^-1) was injected through different ways. 2, 7 and 14 d after injection, GFP expression in left kidney, right kidney, liver and lung was eval- uated by fluorescence microscope and computer software. Results GFP gene expressed in kidey and reached peak 7 d after injection expression. Conclusion rAV vector-mediated report gene can be transducted in kidney. The rAV-mediated transgene expression in kidney is a potential strategy in the treatment of renal diseases.
出处 《基础医学与临床》 CSCD 北大核心 2008年第9期982-985,共4页 Basic and Clinical Medicine
基金 国家自然科学基金(30570868) 浙江省自然科学基金(Y204145)
关键词 重组腺病毒 肾脏 基因 大鼠 recombinant adenovirus kidney gene rat
  • 相关文献

参考文献8

  • 1张新庆.基因治疗风险中的非技术因素分析[J].基础医学与临床,2005,25(5):392-396. 被引量:5
  • 2Isaka Y. Gene therapy targeting kidney diseases: routes and vehicles [ J ]. Clin Exp Nephrol, 2006,10 (4) :229 - 235.
  • 3Fujishiro J, Takeda S, Takeno Y, et al. Gene transfer to the rat kidney in vivo and ex vivo using an adenovirus vector: factors influencing transgene expression [ J ]. Nephrol Dial Transplant, 2005,20 (7) : 1385 - 1391.
  • 4Bledsoe G, Shen B, Yao Y, et al. Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery[J]. Hum Gene Ther, 2006, 17(5) :545 - 555.
  • 5Thirion C, Lochmuller I-I, Ruzsics Z, et al. Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy [ J ]. Hum Gene Ther, 2006,17(2) :193 -205.
  • 6Jaber BL, Madias NE. Progression of chronic kidney disease: can it be prevented or arrested? [ J ]. Am J Med, 2005,118 (12) : 1323 - 1330.
  • 7Koike K, Utsunomiya Y. Gene therapy for kidney diseases : Inflamed site-specific transgenesis using a stem cell [ J ]. Nippon Rinsho, 2006,64 Suppl 2:667 - 671.
  • 8Kapturczak MH, Chen S, Agarwal A. Adeno-associated virus vector-mediated gene delivery to the vasculature and kidney [ J ]. Aeta Biochim Polonica, 2005,52 ( 2 ) : 293 - 299.

二级参考文献9

  • 1Cavazzana-Calvo M, Hacein-Bey S, de Saint Basil G,et al.Gene therapy of human severe combined immunodeficiency (SCID) X1disease[J]. Science,2000,288:669-672.
  • 2Cavazzana-Calvo M,Thrasher A,Mavilio F, et al.The future of gene therapy Balancing the risks and benefits of clinical trial[J]. Nature,2004,427:779-781.
  • 3Fox JL.US panel advises resumption of gene trials [J]. Nat Biotechnol, 2002,20(11):1068-1069.
  • 4Lehrman S. Virus treatment questioned after gene therapy death[J]. Nature,1999,401:517-518.
  • 5Viscusi WK.The value of a statistical life:a critical review of market estimates throughout the world[J]. J Risk Uncertainty,2003,27:1:5-76.
  • 6Edelstein ML,Abedi MR,Wixon,J.Gene therapy clinical triah worldwide 1989-2004 an overview[J].J G.ene Medicine,2004,6:597-602.
  • 7Thompson,Dennis F.Understanding financial conflicts of interest[J]. New England J Medicine,1993,329:452.
  • 8Orkin,SH,Motulsky AG. Report and recommendations of the panel to assess the NIH investment in research on gene therapy[R]. Washington DC: National Institutes of Health, 1995.
  • 9张新庆.基因治疗的含义、特点及影响[J].自然杂志,2003,25(3):153-156. 被引量:8

共引文献4

同被引文献15

  • 1李青,刘殿武,肖永红,刘辉,何海艳.不同剂量不同载体不同途径的肝再生增强因子重组质粒抗大鼠肝纤维化疗效比较[J].第三军医大学学报,2006,28(18):1833-1836. 被引量:5
  • 2中华人民共和国科学技术部.关于善待实验动物的指导性意见.2006.09-30
  • 3Guerre-Millo M.Adipose tissue hormones.J Endocrinol Invest.2002;25(10):855-861.
  • 4Fukuhara A,Matsuda M,Nishizawa M,et al.Visfatin:a protein secreted by visceral fat that mimics the effects of insulin.Science.2005;307(5708):426-430.
  • 5Kondo H,Shimomura I,Matsukawa Y,et al.Association of adiponectin mutation with type 2 diabetes:a candidate gene for the insulin resistance syndrome.Diabetes.2002;51 (7):2325-2328.
  • 6Looker HC,Krakoff J,Funahashi T,et al.Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with Type 2 diabetes.J Clin Endocrinol Metab.2004;89(8):4010-4017.
  • 7Koshimura J,Fujita H,Narita T,et al.Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy.Biochem Biophys Res Commun.2004;316(1):165-169.
  • 8Saraheimo M,Forsblom C,Fagerudd J,et al.Serum adiponectin is increased in type 1 diabetic patients with nephropathy.Diabetes Care.2005;28(6):1410-1414.
  • 9Schalkwijk CG,Chaturvedi N,Schram MT,et al.Adiponectin is inversely associated with renal function in type 1 diabetic patients.Clin Endocrinol Metab.2006;91(1):129-135.
  • 10袁芳,刘伏友,刘映红,易斌,田俊玮.脂联素对高糖诱导系膜细胞活性氧和内皮一氧化氮合成酶产生的影响[J].中华肾脏病杂志,2009,25(9):725-727. 被引量:1

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部